Search
Migraine Clinical Trials in Kansas City, MO
A listing of 5 Migraine clinical trials in Kansas City, MO actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 5 of 5
The city of Kansas City, Missouri, currently has 5 active clinical trials seeking participants for Migraine research studies.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Migraine Research Study
Recruiting
Are you or someone you know over 18, have an iphone, fluent in English, and living with migraines? We want to hear from you! We are conducting a migraine research study and we need participants! Your participation could make a significant impact on the future of migraine treatment.
Conditions:
Migraine
Migraine Disorders
Migraine Headache
Chronic Migraine
Headache
Featured Trial
Kids and Teens Migraine Clinical Study
Recruiting
We are looking for adolescents who experience migraines to take part in a clinical trial. No health insurance is required. The study medicine and any trial-related procedures will be provided.
Conditions:
Migraine
Migraine Disorders
Migraine Headache
Chronic Migraine
Migraine Without Aura
Featured Trial
Migraine Treatment Study
Recruiting
We understand how migraines can disrupt daily living activities like relationships with loved ones, work, social life, and your overall well-being and health. The goal of this study is to find out if an investigational medication helps treat migraine pain and to determine the best doses to test in future studies.
Conditions:
Migraine
Migraine Disorders
Migraine Headache
Chronic Migraine
Migraine Without Aura
Featured Trial
Migraine Treatment Study
Recruiting
We understand how migraines can disrupt daily living activities like relationships with loved ones, work, social life, and your overall well-being and health. The goal of this study is to find out if an investigational medication helps treat migraine pain and to determine the best doses to test in future studies.
Conditions:
Migraine
Migraine Disorders
Migraine Headache
Chronic Migraine
Migraine Without Aura
Featured Trial
Migraine Treatment Study
Recruiting
We understand how migraines can disrupt daily living activities like relationships with loved ones, work, social life, and your overall well-being and health. The goal of this study is to find out if an investigational medication helps treat migraine pain and to determine the best doses to test in future studies.
Conditions:
Migraine
Migraine Disorders
Migraine Headache
Chronic Migraine
Migraine Without Aura
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Recruiting
The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Gender:
ALL
Ages:
Between 6 years and 17 years
Trial Updated:
04/17/2025
Locations: Children Mercy Pediatric Clinical Research Unit, Kansas City, Missouri
Conditions: Episodic Migraine
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
Recruiting
The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.
Gender:
ALL
Ages:
Between 6 years and 17 years
Trial Updated:
04/17/2025
Locations: Children's Mercy Hospital, Kansas City, Missouri
Conditions: Migraine
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
Recruiting
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
Gender:
ALL
Ages:
Between 6 years and 17 years
Trial Updated:
04/17/2025
Locations: Children's Mercy Hospital, Kansas City, Missouri
Conditions: Migraine
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
Recruiting
The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Gender:
ALL
Ages:
Between 12 years and 17 years
Trial Updated:
04/17/2025
Locations: Children Mercy Pediatric Clinical Research Unit, Kansas City, Missouri
Conditions: Chronic Migraine
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
Recruiting
This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to \<12 years) and adolescents (12 to \<18 years) with episodic migraine. The study hypothesis is that in pediatric participants with episodic migraine, the combined erenumab dose group has a greater reduction from baseline to week 9 through week 12 (month 3) in monthly migraine days (MMDs) when compared with placebo in the double-blind treatment phase (DBTP).
Gender:
ALL
Ages:
Between 6 years and 17 years
Trial Updated:
04/09/2025
Locations: Childrens Mercy Hospital and Clinics, Kansas City, Missouri
Conditions: Migraine
1 - 5 of 5